Literature DB >> 8155122

Hypercholesterolaemia: not all cases warrant treatment.

J Patmore1, S Coyle, R Jones, G Wieringa.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8155122      PMCID： PMC1679111          DOI： 10.1136/bmj.307.6912.1125

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Gonadal steroid effects on plasma lipoproteins and individual phospholipids.

Authors:  A Gustafson; A Svanborg
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

2.  Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides.

Authors:  L A Carlson; B Kolmodin-Hedman
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

3.  Disorders of serum alpha-lipoproteins after alcoholic intoxication.

Authors:  B G Johansson; C B Laurell
Journal:  Scand J Clin Lab Invest       Date:  1969-05       Impact factor: 1.713

4.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

5.  Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds.

Authors:  C J Glueck; R W Fallat; F Millett; P Gartside; R C Elston; R C Go
Journal:  Metabolism       Date:  1975-11       Impact factor: 8.694

6.  Lipid screening: is it enough to measure total cholesterol concentration?

Authors:  H A Neil; D Mant; L Jones; B Morgan; J I Mann
Journal:  BMJ       Date:  1990-09-22

7.  Laboratory facilities for investigating lipid disorders in the United Kingdom: results of the British Hyperlipidaemia Association survey.

Authors:  M F Laker; J P Reckless; D J Betteridge; P N Durrington; J P Miller; D P Nicholls; J Shepherd; G R Thompson
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

8.  Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.

Authors:  G R Warnick; R H Knopp; V Fitzpatrick; L Branson
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

9.  Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.

Authors:  C J Glueck; P Gartside; R W Fallat; J Sielski; P M Steiner
Journal:  J Lab Clin Med       Date:  1976-12

10.  Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia.

Authors:  J Koizumi; H Mabuchi; A Yoshimura; I Michishita; M Takeda; H Itoh; Y Sakai; T Sakai; K Ueda; R Takeda
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162
  10 in total
  4 in total

1.  Drug treatment of hypercholesterolaemia. Establish diagnosis before treatment.

Authors:  M D Feher; A S Wierzbicki; T M Reynolds
Journal:  BMJ       Date:  1994-01-01

2.  Drug treatment of hypercholesterolaemia. Determine cardiac risk.

Authors:  N Capps; A Hartland
Journal:  BMJ       Date:  1994-01-01

3.  Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established.

Authors:  T M Reynolds; A S Wierzbicki; M D Feher
Journal:  BMJ       Date:  1994-11-19

4.  Drug treatment of hypercholesterolaemia. Review criteria for cholesterol tests.

Authors:  M Lough
Journal:  BMJ       Date:  1994-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.